NASA Scientists Concerned About Toilet Microbes on ISS

Advertisement
By Indo-Asian News Service | Updated: 23 November 2018 16:39 IST

NASA is concerned over the strains of the bacterium Enterobacter, identified on the toilets of the International Space Station's (ISS), which can raise potential health implications for future missions, say Indian-origin scientists at the US space agency.

Five strains of 'Enterobacter' bacterium isolated from the space toilet and the exercise platform on the ISS in March 2015 were investigated in a study led by a team from NASA's Jet Propulsion Laboratory (JPL) and California Institute of Technology (Caltech), US.

Advertisement

Genome sequencing of the samples revealed that all five strains belonged to a single species, Enterobacter bugandensis (E.bugandensis).

While these were not pathogenic to humans, E.bugandensis was linked to disease in neonates and a compromised patient, who were admitted to three different hospitals (in east Africa, Washington state and Colorado), the researchers said.

Advertisement

"Given the multi-drug resistance results for these ISS E.bugandensis genomes and the increased chance of pathogenicity we have identified, these species potentially pose important health considerations for future missions," said lead author Nitin Singh from NASA-JPL Caltech.

"However, it is important to understand that the strains found on the ISS were not virulent, which means they are not an active threat to human health, but something to be monitored," he added.

Advertisement

For the study, published in the journal BMC Microbiology, the team compared the ISS strains to all publicly available genomes of 1,291 Enterobacter strains collected on Earth.

They found that the ISS isolates had similar antimicrobial resistance patterns to the three clinical strains found on Earth and that they included 112 genes involved in virulence, disease and defence.

Advertisement

Using computer analyses, they predicted a 79 per cent probability that they may potentially cause disease.

"Whether or not an opportunistic pathogen like E.bugandensis causes disease and how much of a threat it is, depends on a variety of factors, including environmental ones," said Kasthuri Venkateswaran, Senior Research Scientist at the JPL.

"Further in vivo studies are needed to discern the impact that conditions on the ISS, such as microgravity, other space, and spacecraft-related factors, may have on pathogenicity and virulence," he noted.

 

Get your daily dose of tech news, reviews, and insights, in under 80 characters on Gadgets 360 Turbo. Connect with fellow tech lovers on our Forum. Follow us on X, Facebook, WhatsApp, Threads and Google News for instant updates. Catch all the action on our YouTube channel.

Further reading: NASA, ISS, JPL
Advertisement

Related Stories

Popular Mobile Brands
  1. Best Phones for Long-Term Use in India
  2. What Is LTPO Display Technology? How It Works, Benefits and Drawbacks
  3. Nothing Reveals Flipkart Big Billion Days Deals for Phone 4 Series, CMF Buds Lineup, More
  1. Nothing Deals Revealed for Phone 4 Series, CMF Buds Lineup, More Ahead of Flipkart's Big Billion Days Sale
  2. F1 25, Hunt: Showdown 1896 and Earth Defense Force: World Brothers 2 Join PS Plus in October
  3. Samsung Galaxy A08 Launched in India With MediaTek Helio G99+ SoC, 6,000mAh Battery: Price, Features
  4. Samsung Galaxy Buds On Unveiled With Clip-On Design, Up to 9.5 Hours of Battery Life: Price, Features
  5. OnePlus Nord Buds 3r Gets Jade Mist Colour Variant in India: Price, Specifications
  6. Crypto Hack Losses Reach $768 Million in September, Marking 2026’s Worst Month
  7. Nike Apex Racing Shoe Launched With Double-Stacked Air Zoom Platform, Carbon Fibre Flyplate
  8. India Sees Stronger Centralised Crypto Exchange Inflows Than Singapore, Australia
  9. Google Announces Gemini 4 Argon With Longer Output Limit: See Features, Availability
  10. Oppo F35 Pro 5G, Oppo F35 5G Appear on Geekbench With MediaTek Chipsets Ahead of India Launch
Download Our Apps
Available in Hindi
© Copyright Red Pixels Ventures Limited 2026. All rights reserved.